EichorEICHOR
Condition: Meningococcal Immunisation Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Meningococcal Immunisation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Menin
Phase N/A · 2 location(s) · Serum Institute of India Pvt. Ltd. · NCT07379151Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Phase 4 · 1 location(s) · Thomas Benfield · NCT04875819Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
Phase 4 · 1 location(s) · University Ghent · NCT06832514Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjug
Phase N/A · 9 location(s) · Sanofi · NCT07621653
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.